Interference with PD-L1/PD-1 co-stimulation during antigen presentation enhances the multifunctionality of antigen-specific T cells

被引:0
|
作者
Breckpot, K. [1 ]
Pen, J. J. [1 ]
De Keersmaecker, B. [1 ]
Heirman, C. [1 ]
Corthals, J. [1 ]
Liechtenstein, T. [1 ,2 ]
Escors, D. [2 ,3 ]
Thielemans, K. [1 ]
机构
[1] Vrije Univ Brussel, Lab Mol & Cellular Therapy, Dept Immunol Physiol, Brussels, Belgium
[2] UCL, Div Infect & Immun, Rayne Inst, London, England
[3] Navarrabiomed FMS, Pamplona, Spain
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:A166 / A167
页数:2
相关论文
共 50 条
  • [41] PD-L1 binding peptide identified by phage peptide display inhibits PD-1/PD-L1 interaction and activates T cells
    Gurung, Smriti
    Khan, Fatima
    Lee, Soo-Woong
    Yoon, Jaewon
    Lee, Byungheon
    CANCER RESEARCH, 2018, 78 (13)
  • [42] Antigen-specific Helios-, Neuropilin-1- Tregs induce apoptosis of autoreactive B cells via PD-L1
    Gotot, Janine
    Dhana, Ermanila
    Yagita, Hideo
    Kaiser, Romina
    Ludwig-Portugall, Isis
    Kurts, Christian
    IMMUNOLOGY AND CELL BIOLOGY, 2018, 96 (08): : 852 - 862
  • [43] Anti-PD-1/PD-L1 Based Combination Immunotherapy to Boost Antigen-Specific CD8+ T Cell Response in Hepatocellular Carcinoma
    Pena-Asensio, Julia
    Calvo, Henar
    Torralba, Miguel
    Miquel, Joaquin
    Sanz-de-Villalobos, Eduardo
    Larrubia, Juan-Ramon
    CANCERS, 2021, 13 (08)
  • [44] Interference with PD-L1/PD-1 co-stimulation results in effective anti-tumour immunity by preventing ligand-induced T cell receptor down-modulation in effector CD8 T cells
    Escors, D.
    Liechtenstein, T.
    Perez-Janices, N.
    Lanna, A.
    Bricogne, C.
    Karwaca, K.
    Guerrero-Setas, D.
    Breckpot, K.
    HUMAN GENE THERAPY, 2013, 24 (12) : A170 - A170
  • [45] A review of PD-1/PD-L1 siRNA delivery systems in immune T cells and cancer cells
    Barati, Mehdi
    Mirzavi, Farshad
    Atabaki, Mahdi
    Bibak, Bahram
    Mohammadi, Mojgan
    Jaafari, Mahmoud Reza
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 111
  • [46] Association between PD-1/PD-L1 and T regulate cells in early recurrent miscarriage
    Li, Guiyu
    Lu, Caixia
    Gao, Jing
    Wang, Xietong
    Wu, Huanling
    Lee, Chao
    Xing, Baoxiang
    Zhang, Qi
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (06): : 6512 - 6518
  • [47] Contributions of PD-1/PD-L1 pathway to interactions of myeloid DCs with T cells in atherosclerosis
    Lee, Jun
    Zhuang, Yan
    Wei, Xin
    Shang, Fujun
    Wang, Jiuping
    Zhang, Ye
    Liu, Xiongtao
    Yang, Yuhui
    Liu, Li
    Zheng, Qiangsun
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2009, 46 (02) : 169 - 176
  • [48] Long-term persistence and functionality of adoptively transferred antigen-specific T cells with genetically ablated PD-1 expression
    Doetsch, Sarah
    Svec, Mortimer
    Schober, Kilian
    Hammel, Monika
    Wanisch, Andreas
    Goekmen, Fuesun
    Jarosch, Sebastian
    Warmuth, Linda
    Barton, Jack
    Cicin-Sain, Luka
    D'Ippolito, Elvira
    Busch, Dirk H.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (10)
  • [49] Chronic Virus Infection Enforces Demethylation of the Locus that Encodes PD-1 in Antigen-Specific CD8+ T Cells
    Youngblood, Ben
    Oestreich, Kenneth J.
    Ha, Sang-Jun
    Duraiswamy, Jaikumar
    Akondy, Rama S.
    West, Erin E.
    Wei, Zhengyu
    Lu, Peiyuan
    Austin, James W.
    Riley, James L.
    Boss, Jeremy M.
    Ahmed, Rafi
    IMMUNITY, 2011, 35 (03) : 400 - 412
  • [50] The upregulation of BTLA and PD-1 defines a novel subset of dysfunctional tumor antigen-specific CD8+T cells
    Fourcade, Julien
    Sun, Zhaojun
    Pagliano, Ornella
    Guillaume, Philippe
    Luescher, Immanuel F.
    Sander, Cindy
    Kirkwood, John M.
    Olive, Daniel
    Kuchroo, Vijay
    Zarour, Hassane M.
    CANCER RESEARCH, 2012, 72